Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) is offered by National Institutes of Health. Max award: Not specified. This is a forecast; the deadline is not set yet.
| Opportunity number | RFA-CA-28-004 |
|---|---|
| Agency | National Institutes of Health |
| Status | Forecasted |
| Posted | Jan 13, 2026 |
| Closes | Not set |
| Award ceiling | Not specified |
| Award floor | Not specified |
| Total program funding | $19,100,000 |
| Expected awards | 6 |
| Who can apply | Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Category | Health |
Summary (excerpt)
Through this limited competition Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications to support continuation of the two distinct biospecimen banking resources: The National Clinical Trials Network (NCTN) Biospecimen Banks (NCTN Biobanks) support the NCI-funded NCTN and the Community Oncology Research Program (NCORP), and The Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) sup…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from National Institutes of Health